Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
-1.45%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$11.2B
AUM Growth
+$1.81B
(+19%)
Cap. Flow
+$2.15B
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
17.38%
Holding
2,302
New
520
Increased
510
Reduced
405
Closed
521
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$609M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$107M |
| 3 |
Walmart
WMT
|
+$85.4M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$82M |
| 5 |
Broadcom
AVGO
|
+$76.1M |
Top Sells
| 1 |
Energy Select Sector SPDR Fund
XLE
|
+$157M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$155M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$142M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.9M |
Sector Composition
| 1 | Technology | 15.93% |
| 2 | Financials | 11.61% |
| 3 | Healthcare | 10.24% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Bandwidth Inc
BAND
$458M
| $137K | ﹤0.01% |
10,433
-34,759
| -77% | -$455K |
|
1427
Babcock & Wilcox
BW
$266M
| $136K | ﹤0.01% |
202,746
| – | – |
|
1428
10x Genomics
TXG
$1.57B
| $134K | ﹤0.01% |
15,393
-184,618
| -92% | -$1.61M |
|
1429
Outset Medical
OM
$241M
| $133K | ﹤0.01% |
12,028
-2
| -0% | -$22 |
|
1430
UNIFI
UFI
$83M
| $132K | ﹤0.01% |
27,465
-46
| -0.2% | -$221 |
|
1431
NovaGold Resources
NG
$2.69B
| $123K | ﹤0.01% |
42,134
-532,757
| -93% | -$1.56M |
|
1432
Ironwood Pharmaceuticals
IRWD
$187M
| $120K | ﹤0.01% |
81,795
+55,729
| +214% | +$81.9K |
|
1433
Prime Medicine
PRME
$693M
| $120K | ﹤0.01% |
+60,368
| New | +$120K |
|
1434
Amylyx Pharmaceuticals
AMLX
$1.05B
| $118K | ﹤0.01% |
33,428
-259
| -0.8% | -$917 |
|
1435
Village Farms International
VFF
$284M
| $115K | ﹤0.01% |
189,300
| – | – |
|
1436
Senseonics Holdings
SENS
$357M
| $114K | ﹤0.01% |
174,383
| – | – |
|
1437
Purple Innovation
PRPL
$116M
| $114K | ﹤0.01% |
150,649
| – | – |
|
1438
Tyra Biosciences
TYRA
$635M
| $112K | ﹤0.01% |
12,093
-3,484
| -22% | -$32.4K |
|
1439
Precigen
PGEN
$1.22B
| $106K | ﹤0.01% |
71,464
| – | – |
|
1440
IAMGOLD
IAG
$6.27B
| $106K | ﹤0.01% |
17,011
-1,975
| -10% | -$12.3K |
|
|
ITOS
1441
DELISTED
iTeos Therapeutics
ITOS
| $105K | ﹤0.01% |
+17,651
| New | +$105K |
|
1442
Allogene Therapeutics
ALLO
$246M
| $104K | ﹤0.01% |
+71,008
| New | +$104K |
|
1443
Open Lending Corp
LPRO
$253M
| $98.3K | ﹤0.01% |
+35,607
| New | +$98.3K |
|
1444
PLAYSTUDIOS Inc
MYPS
$120M
| $90K | ﹤0.01% |
70,871
-208
| -0.3% | -$264 |
|
1445
4D Molecular Therapeutics
FDMT
$324M
| $82K | ﹤0.01% |
25,399
-2,035
| -7% | -$6.57K |
|
1446
ImmunityBio
IBRX
$2.43B
| $73K | ﹤0.01% |
+24,253
| New | +$73K |
|
|
GAN
1447
DELISTED
GAN Ltd
GAN
| $71.6K | ﹤0.01% |
40,436
| – | – |
|
1448
Lyell Immunopharma
LYEL
$251M
| $66.9K | ﹤0.01% |
6,216
| – | – |
|
|
WW
1449
DELISTED
WW International
WW
| $61.2K | ﹤0.01% |
117,100
| – | – |
|
1450
DocGo
DCGO
$148M
| $58.9K | ﹤0.01% |
22,329
| – | – |
|